• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Pharma & Human Health

Revealing the mysteries within microbial genomes

September 1, 2024 Microbiome Times

A new technique developed at Lawrence Berkeley National Laboratory (Berkeley Lab) will make it much easier for researchers to discover the traits or activities encoded by genes of unknown function in microbes, a key step […]

Pharma & Human Health

Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods

September 1, 2024 Microbiome Times

Bifidobacterium infantis M-63 is a unique probiotic strain of human-residential bifidobacteria (HRB) – bifidobacteria that naturally reside in the human gut – and is renowned for its ability to utilize human milk oligosaccharides (HMO) found […]

Pharma & Human Health

Researchers develop probiotic to ameliorate ulcerative colitis

September 1, 2024 Microbiome Times

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed a probiotic-based therapeutic that synergistically restores intestinal redox and microbiota homeostasis. This therapeutic effectively relieved inflammation and reduced colonic […]

Pharma & Human Health

Mining the microbiome: Uncovering new antibiotics inside the human gut

August 27, 2024 Microbiome Times

The average human gut contains roughly 100 trillion microbes, many of which are constantly competing for limited resources. “It’s such a harsh environment,” says César de la Fuente, Presidential Assistant Professor in Bioengineering and in Chemical […]

Editor's Choice

Ferring v Finch: Ripples from the Decision

August 14, 2024 Craig Thomson and Mark FitzGerald

Three patent claims, one present in each of three US patents held by the Finch Therapeutics Group Inc. (Finch), have been found to have been infringed by Ferring Pharmaceuticals Inc.’s (Ferring) activities in the US […]

Finance

Transferring an LBP program from one CDMO to another

July 31, 2024 Claire Derlot

Choosing the right CDMO partner is one of the hardest steps a CEO must undertake when embarking on their drug development journey. The CEO must consider the quality, experience, and cost of a prospective partner, […]

Pharma & Human Health

Viruses use freeloading genes as weapons

July 26, 2024 Nick Gallo

Curious bits of DNA tucked inside genomes across all kingdoms of life historically have been disregarded since they don’t seem to have a role to play in the competition for survival. Or so researchers thought. […]

Finance

Ancilia Biosciences Announces Closing of $4.2 Million Financing

July 18, 2024 Microbiome Times

Ancilia Biosciences, Inc., (Ancilia Bio), a biotechnology company harnessing the natural power of CRISPR to create bacterial therapies and products with immunity against destructive viruses, today announced the closing of a $4.2 million financing. The […]

Editor's Choice

Eligo Publishes a Landmark Study in Nature That Unlocks Genome Editing of Bacteria in the Gut

July 10, 2024 Nick Gallo

Eligo Bioscience, a pioneering gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, publishes a landmark study in Nature that unlocks Genome Editing of Bacteria in the Gut. […]

Pharma & Human Health

New findings may fix the replicability crisis in microbiome research

July 10, 2024 Microbiome Times

Scientists at University of California San Diego have discovered another factor that affects the composition of the gut microbiome: time of day. In fact, the scientists have found that time of day is such an […]

Animal Health

MIT engineers find a way to protect microbes from extreme conditions

July 9, 2024 Microbiome Times

Microbes that are used for health, agricultural, or other applications need to be able to withstand extreme conditions, and ideally the manufacturing processes used to make tablets for long-term storage. MIT researchers have now developed […]

Posts navigation

« 1 … 9 10 11 … 85 »

Sign Up to Free Newsletter

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter